Enzymatic metabolism of flavonoids by gut microbiota and its impact on gastrointestinal cancer

55Citations
Citations of this article
87Readers
Mendeley users who have this article in their library.

Abstract

Gastrointestinal (GI) cancer is a prevalent global health disease with a massive burden on health care providers. Internal and external factors such as obesity, smoking, diet (red meat), low socioeconomic status and infection with Helicobacter pylori are the critical risk factors of GI cancers. Flavonoids are natural phenolic compounds found abundantly in fruits and vegetables. Upon ingestion, 90% of flavonoids consumed require further enzymatic metabolism by the gut microbiome to enhance their bioavailability and absorption. Several epidemiological studies reported that consumption of flavonoids and their enzymatic conversion by gut microbes is strongly associated with the reduced risk of GI cancer development. This review summarizes the current knowledge on the enzymatic conversion of flavonoids by the human gut microbiome. It also addresses the underlying anti-GI cancer effects on metabolic pathways such as apoptosis and cellular proliferation. Overall, metabolites produced from flavonoid’s enzymatic conversion illustrate anti-GI cancer effects, but the mechanisms of action need further clarification.

Cite

CITATION STYLE

APA

Al-Ishaq, R. K., Liskova, A., Kubatka, P., & Büsselberg, D. (2021, August 2). Enzymatic metabolism of flavonoids by gut microbiota and its impact on gastrointestinal cancer. Cancers. MDPI AG. https://doi.org/10.3390/cancers13163934

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free